Author:
Peng Hao,He YuanPeng,Hu Yuepeng,Sheng Siqi,Maitiyasen Maierhaba,Li jingfeng,Liu Yvxuan,Hou Xinyu,Song Haizhu,Yi Jun
Funder
Basic Research Program of Jiangsu Province
Nanjing Jinling Hospital
Nanjing University
Reference41 articles.
1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA: A Cancer J. Clin.,2021
2. Identification of genomic alterations in oesophageal squamous cell cancer;Song;Nature,2014
3. Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: a phase II study;Ohnuma;Cancer Sci.,2018
4. Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial;Kato;Lancet Oncol.,2019
5. The potential of herb medicines in the treatment of esophageal cancer;Ying;Biomed. Pharmacother.,2018